Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (241-250 of 496) with videos related to

Pageof 50
Sort By:
Gynecologic Oncology|October 18, 2011
Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS)Kate J Lifford, Lindsay Fraser, Adam N Rosenthal, et al.
Indian Heart Journal|February 27, 2013
Population-based intervention for cardiovascular diseases related knowledge and behaviours in Asian Indian womenRavindra Mohan Pandey, Aachu Agrawal, Anoop Misra, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2012
Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomyRanjit Manchanda, Anna Silvanto, Ahmed Abdelraheim, et al.
Endocrine-Related Cancer|December 27, 2011
Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal womenEvangelia-Ourania Fourkala, Alexey Zaikin, Matthew Burnell, et al.
Nature Communications|May 25, 2016
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolutionThomas E Bartlett, Kantaraja Chindera, Jacqueline McDermott, et al.
Clinical Chemistry|January 23, 2010
Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancerJohn F Timms, Rainer Cramer, Stephane Camuzeaux, et al.
Ebiomedicine|January 6, 2022
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetesLucy Oldfield, Anthony Evans, Rohith Gopala Rao, et al.
Cancer|November 13, 2019
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancerWei-Lei Yang, Zhen Lu, Jing Guo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 11, 2019
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian CancerArchana R Simmons, Evangelia Ourania Fourkala, Aleksandra Gentry-Maharaj, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profilingAli Tiss, John F Timms, Celia Smith, et al.
Pageof 50

Showing results (241-250 of 496) with videos related to

Sort By:
Pageof 50
Gynecologic Oncology|October 18, 2011
Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS)Kate J Lifford, Lindsay Fraser, Adam N Rosenthal, et al.
Indian Heart Journal|February 27, 2013
Population-based intervention for cardiovascular diseases related knowledge and behaviours in Asian Indian womenRavindra Mohan Pandey, Aachu Agrawal, Anoop Misra, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2012
Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomyRanjit Manchanda, Anna Silvanto, Ahmed Abdelraheim, et al.
Endocrine-Related Cancer|December 27, 2011
Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal womenEvangelia-Ourania Fourkala, Alexey Zaikin, Matthew Burnell, et al.
Nature Communications|May 25, 2016
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolutionThomas E Bartlett, Kantaraja Chindera, Jacqueline McDermott, et al.
Clinical Chemistry|January 23, 2010
Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancerJohn F Timms, Rainer Cramer, Stephane Camuzeaux, et al.
Ebiomedicine|January 6, 2022
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetesLucy Oldfield, Anthony Evans, Rohith Gopala Rao, et al.
Cancer|November 13, 2019
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancerWei-Lei Yang, Zhen Lu, Jing Guo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 11, 2019
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian CancerArchana R Simmons, Evangelia Ourania Fourkala, Aleksandra Gentry-Maharaj, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profilingAli Tiss, John F Timms, Celia Smith, et al.
Pageof 50